Additionally, we examined the clinical association between the programmed death-ligand 1 (PD-L1) tumor proportion score (TPS) and TLSs in early-stage EGFR-mutant lung adenocarcinoma patients. The gene discussed is EGFR; the disease is lung adenocarcinoma.